ArticleNature medicine2020

Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.

Priscilla K Brastianos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.